{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:49:39Z","timestamp":1787240979349,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.neulet.2021.136243","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T23:15:51Z","timestamp":1631229351000},"page":"136243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The impact of common genetic variants in cognitive decline in the first seven years of Parkinson\u2019s disease: A longitudinal observational study"],"prefix":"10.1016","volume":"764","author":[{"given":"Janete","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Ushakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Doitsidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Tzoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole-Bj\u00f8rn","family":"Tysnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8160-3211","authenticated-orcid":false,"given":"Ingvild","family":"Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenn Freddy","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7142-0078","authenticated-orcid":false,"given":"Jodi","family":"Maple-Gr\u00f8dem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neulet.2021.136243_b0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","article-title":"Cognitive decline in Parkinson disease","volume":"13","author":"Aarsland","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.neulet.2021.136243_b0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/0891988712464823","article-title":"Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden","volume":"25","author":"Leroi","year":"2012","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.neulet.2021.136243_b0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41531-018-0055-3","article-title":"Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health","volume":"4","author":"Goldman","year":"2018","journal-title":"NPJ Parkinsons Dis"},{"issue":"2","key":"10.1016\/j.neulet.2021.136243_b0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JPD-150762","article-title":"and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression","volume":"6","author":"Paul","year":"2016","journal-title":"Journal of Parkinson's disease"},{"issue":"4","key":"10.1016\/j.neulet.2021.136243_b0025","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mds.24946","article-title":"Genetic influences on cognitive decline in Parkinson's disease","volume":"27","author":"Morley","year":"2012","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.neulet.2021.136243_b0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.0b013e31827b1a07","article-title":"Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia","volume":"80","author":"Gomperts","year":"2013","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neulet.2021.136243_b0035","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","article-title":"and SNCA genes and cognitive performance in Parkinson disease","volume":"71","author":"Mata","year":"2014","journal-title":"JAMA neurology"},{"issue":"Pt 11","key":"10.1016\/j.neulet.2021.136243_b0040","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2021.136243_b0045","doi-asserted-by":"crossref","unstructured":"N.M. van der Kolk, A.D. Speelman, M. van Nimwegen, R.P. Kessels, J. IntHout, M. Hakobjan, M. Munneke, B.R. Bloem, B.P. van de Warrenburg, BDNF polymorphism associates with decline in set shifting in Parkinson's disease, Neurobiol Aging 36(3) (2015) 1605 e1-6.","DOI":"10.1016\/j.neurobiolaging.2014.08.023"},{"issue":"1","key":"10.1016\/j.neulet.2021.136243_b0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/ane.12812","article-title":"Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease","volume":"137","author":"B\u00e4ckstr\u00f6m","year":"2018","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"10.1016\/j.neulet.2021.136243_b0055","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/jnnp.2008.168211","article-title":"Norwegian ParkWest study, Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study","volume":"80","author":"Alves","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.neulet.2021.136243_b0060","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1212\/WNL.0000000000003634","article-title":"Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study","volume":"88","author":"Pedersen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2021.136243_b0065","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3389\/fpsyg.2015.01389","article-title":"A word on standardization in longitudinal studies: don't","volume":"6","author":"Moeller","year":"2015","journal-title":"Front Psychol"},{"key":"10.1016\/j.neulet.2021.136243_b0070","doi-asserted-by":"crossref","unstructured":"M. Emre, D. Aarsland, R. Brown, D.J. Burn, C. Duyckaerts, Y. Mizuno, G.A. Broe, J. Cummings, D.W. Dickson, S. Gauthier, J. Goldman, C. Goetz, A. Korczyn, A. Lees, R. Levy, I. Litvan, I. McKeith, W. Olanow, W. Poewe, N. Quinn, C. Sampaio, E. Tolosa, B. Dubois, Clinical diagnostic criteria for dementia associated with Parkinson's disease, Mov Disord 22(12) (2007) 1689-707; quiz 1837.","DOI":"10.1002\/mds.21507"},{"issue":"3","key":"10.1016\/j.neulet.2021.136243_b0075","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.neulet.2021.136243_b0080","article-title":"Association of a BACE1 Gene Polymorphism with Parkinson's Disease in a Norwegian Population","volume":"2015","author":"Lange","year":"2015","journal-title":"Parkinsons Dis"},{"issue":"10","key":"10.1016\/j.neulet.2021.136243_b0085","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.64","article-title":"Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease","volume":"33","author":"Gaare","year":"2018","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.neulet.2021.136243_b0090","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.neulet.2021.136243_b0095","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nn1438","article-title":"Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype","volume":"8","author":"Meyer-Lindenberg","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.neulet.2021.136243_b0100","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.biopsych.2019.05.014","article-title":"Which Dopamine Polymorphisms Are Functional? Systematic Review and Meta-analysis of COMT, DAT, DBH, DDC, DRD1-5, MAOA, MAOB, TH, VMAT1, and VMAT2","volume":"86","author":"Tunbridge","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"18","key":"10.1016\/j.neulet.2021.136243_b0105","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1523\/JNEUROSCI.0774-07.2007","article-title":"Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease","volume":"27","author":"Williams-Gray","year":"2007","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"issue":"Pt 10","key":"10.1016\/j.neulet.2021.136243_b0110","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/brain\/awu201","article-title":"Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study","volume":"137","author":"Nombela","year":"2014","journal-title":"Brain"},{"issue":"15","key":"10.1016\/j.neulet.2021.136243_b0115","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/mds.23319","article-title":"Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease","volume":"25","author":"Hoogland","year":"2010","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neulet.2021.136243_b0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000341998","article-title":"Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis","volume":"11","author":"Kehagia","year":"2013","journal-title":"Neuro-degenerative diseases"},{"issue":"2","key":"10.1016\/j.neulet.2021.136243_b0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11682-018-0022-y","article-title":"Reduced gray matter volume in cognitively preserved COMT (158)Val\/Val Parkinson's disease patients and its association with cognitive decline","volume":"14","author":"Sampedro","year":"2020","journal-title":"Brain imaging and behavior"},{"key":"10.1016\/j.neulet.2021.136243_b0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2018.11.001","article-title":"Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease","volume":"124","author":"Sampedro","year":"2019","journal-title":"Neurobiology of disease"},{"issue":"3","key":"10.1016\/j.neulet.2021.136243_b0135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00415-009-0119-8","article-title":"Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease","volume":"256","author":"Williams-Gray","year":"2009","journal-title":"J Neurol"},{"issue":"8","key":"10.1016\/j.neulet.2021.136243_b0140","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archneur.62.8.1265","article-title":"Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study","volume":"62","author":"de Lau","year":"2005","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.neulet.2021.136243_b0145","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.parkreldis.2014.06.006","article-title":"Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG","volume":"20","author":"Zhu","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"10.1016\/j.neulet.2021.136243_b0150","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mds.27204","article-title":"APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease","volume":"33","author":"Tropea","year":"2018","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.neulet.2021.136243_b0155","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20198443","article-title":"Association between BDNF G196A (Val66Met) polymorphism and cognitive impairment in patients with Parkinson's disease: a meta-analysis","volume":"52","author":"Wang","year":"2019","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.neulet.2021.136243_b0160","doi-asserted-by":"crossref","unstructured":"I.F. Mata, C.O. Johnson, J.B. Leverenz, D. Weintraub, J.Q. Trojanowski, V.M. Van Deerlin, B. Ritz, R. Rausch, S.A. Factor, C. Wood-Siverio, J.F. Quinn, K.A. Chung, A.L. Peterson-Hiller, A.J. Espay, F.J. Revilla, J. Devoto, D. Yearout, S.C. Hu, B.A. Cholerton, T.J. Montine, K.L. Edwards, C.P. Zabetian, Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease, Neurobiol Aging 56 (2017) 211 e1-211 e7.","DOI":"10.1016\/j.neurobiolaging.2017.04.009"},{"issue":"1","key":"10.1016\/j.neulet.2021.136243_b0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/mds.26359","article-title":"GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease","volume":"31","author":"Mata","year":"2016","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neulet.2021.136243_b0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.21192","article-title":"Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease","volume":"62","author":"Goris","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neulet.2021.136243_b0175","doi-asserted-by":"crossref","unstructured":"H. Iwaki, C. Blauwendraat, H.L. Leonard, J.J. Kim, G. Liu, J. Maple-Grodem, J.C. Corvol, L. Pihlstrom, M. van Nimwegen, S.J. Hutten, K.H. Nguyen, J. Rick, S. Eberly, F. Faghri, P. Auinger, K.M. Scott, R. Wijeyekoon, V.M. Van Deerlin, D.G. Hernandez, J.R. Gibbs, C. International Parkinson's Disease Genomics, K.N. Chitrala, A.G. Day-Williams, A. Brice, G. Alves, A.J. Noyce, O.B. Tysnes, J.R. Evans, D.P. Breen, K. Estrada, C.E. Wegel, F. Danjou, D.K. Simon, O. Andreassen, B. Ravina, M. Toft, P. Heutink, B.R. Bloem, D. Weintraub, R.A. Barker, C.H. Williams-Gray, B.P. van de Warrenburg, J.J. Van Hilten, C.R. Scherzer, A.B. Singleton, M.A. Nalls, Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts, Mov Disord 34(12) (2019) 1839-1850.","DOI":"10.1002\/mds.27845"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021006224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021006224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:40:20Z","timestamp":1759624820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394021006224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":35,"alternative-id":["S0304394021006224"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2021.136243","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of common genetic variants in cognitive decline in the first seven years of Parkinson\u2019s disease: A longitudinal observational study","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2021.136243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"136243"}}